Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FL2C4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $328,166
Award facts
- Contract value 100% obligated
- $328,166.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $328,166.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Keytruda 100 mg/4 mL vials. This firm fixed-price delivery order is scheduled for completion by October 20, 2025, and was issued on September 27, 2025. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the federal procurement marketplace despite its small business status.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at approximately $500 million and valid through November 2026. Through this SPE2DB program vehicle, the contractor provides comprehensive pharmaceutical products and medical supplies to Department of Defense healthcare facilities nationwide. The company's established portfolio includes oncology treatments, biologics, prescription medications, and specialty pharmaceutical products essential to military healthcare operations. As a consistent DLA supplier, DMS Pharmaceutical Group plays a significant role in ensuring the availability of critical medications, including branded cancer therapies like Keytruda, to military health systems.
Quick answers
Who was awarded contract SPE2DB25FL2C4?
SPE2DB25FL2C4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 27, 2025.
How much is contract SPE2DB25FL2C4 worth?
The government has obligated $328,166 on SPE2DB25FL2C4.
Is contract SPE2DB25FL2C4 an order under another contract?
Yes. SPE2DB25FL2C4 is a delivery order under SPE2DB20D9331, an indefinite delivery contract.
Was contract SPE2DB25FL2C4 competed?
The extent of competition for SPE2DB25FL2C4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award